^
    CANCER:

    Small Intestinal Carcinoma





    Show legend
    Group by Gene:
    0
    Thymidylate synthase inhibitor
    capecitabine
    5-fluorouracil
    PD1 inhibitor
    dostarlimab-gxly
    		1
    PD1 inhibitor
    pembrolizumab
    tislelizumab
    nivolumab
    2
    PD1 inhibitor, CTLA4 inhibitor
    pembrolizumab + ipilimumab
    nivolumab + ipilimumab
    3
    VEGF-A inhibitor
    bevacizumab
    4
    Bcl2 inhibitor, Tubulin inhibitor
    albumin-bound paclitaxel
    5
    Topoisomerase I inhibitor
    irinotecan
    6
    Tubulin polymerization promoter, Bcl2 inhibitor
    carboplatin + paclitaxel
    paclitaxel
    7
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    larotrectinib
    8
    KRAS G12C inhibitor
    BI 1823911
    9
    MEK inhibitor, BRAF inhibitor
    trametinib + dabrafenib
    10
    RET inhibitor
    selpercatinib
    LV5FU2
    GTX
    FOLFIRINOX
    		11
    Chemotherapy
    mFOLFOX6
    BEV + CAPOX
    FOLFOX
    FOLFIRI
    CAPOX
    12
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor
    gemcitabine + paclitaxel
    13
    DNA synthesis inhibitor, Bcl2 inhibitor, Tubulin inhibitor
    gemcitabine + albumin-bound paclitaxel
    14
    Microtubule stabilizer, Tubulin polymerization promoter, DNA synthesis inhibitor
    gemcitabine + docetaxel
    15
    Microtubule stabilizer, Tubulin polymerization promoter
    docetaxel
    16
    TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
    entrectinib
    No biomarker
    MSI-H/dMMR
    MSI-L/dMMR
    NTRK1 fusion
    NTRK2 fusion
    NTRK3 fusion
    BRAF V600E
    TMB-H
    RET fusion
    TP53 S12F + KRAS G12D + TMB-L
    MSI-H/dMMR + TMB-H + PD-L1 overexpression
    BRAF V600E + MSI-H
    VEGFA overexpression
    KRAS G12C
    MSI-H/dMMR + TMB-L
    PTEN mutation + MSI-H/dMMR